This is the authors' abstract. We don't add key points for this paper.
In this study, research and development for the synthetic process of a PDE10A inhibitor are described; in particular, an efficient regioselective construction of the quinoxaline unit, a cost-effective pyrazolo[1,5- a ]pyrimidine formation, and a cost-saving approach in a nucleophilic aromatic substitution (S N Ar) reaction by introducing oxazolidinone as an electron-withdrawing group to a chloropyrazolo[1,5- a ]pyrimidine core are key points. The newly developed process has been successfully scaled up to 40 kg. Furthermore, a one-pot tandem reaction from aminopyrazole to dichloropyrazolo[1,5- a ]pyrimidine by activating malonic acid with POCl 3 was discovered. The finding contributed to avoiding isolation of the hygroscopic pyrazolo[1,5- a ]pyrimidin-5(4 H )-one intermediate, which caused complicated filtration and drying processes observed in the first scale-up campaign.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yamagami et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: